Skip to Content

T21 (Risedronate sodium delayed-release 35 mg)

This pill with imprint "T21" is White, Elliptical / Oval and has been identified as Risedronate sodium delayed-release 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Risedronate is used in the treatment of prevention of osteoporosis; paget's disease; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Risedronate sodium delayed-release

Imprint:
T21
Strength:
35 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc
National Drug Code (NDC):
00093-5509

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide